IDH2 and central nervous system cancer: Ameta-analysis by Suh et al (53) showed that acombination of diffusion- and perfusion-weighted MRI allows for the noninvasiveprediction of IDH mutational status in all-grade gliomas with asummary sensitivity of 86% and specificity of 87%.